#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Activated PI3 kinase delta syndrome Juvenile chronic myelomonocytic leukaemia Friedreich's ataxia Hereditary haemorrhagic telangiectasia Aicardi-Goutieres syndrome Scleroderma associated digital ulcer Extraskeletal ossification Pancreatic carcinoma metastatic Fibrodysplasia ossificans progressiva Nephropathy Warm autoimmune haemolytic anaemia Pericarditis Salivary gland cancer Interstitial lung disease Polymyositis More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Treatment Pleural mesothelioma malignant – Diagnostics Friedreich’s ataxia Prader-Willi syndrome – Diagnostics Burkitt’s lymphoma – Diagnostics Castleman’s disease – Basic Information Pulmonary fibrosis – Trials in Disease Tuberous sclerosis complex – Diagnostics Osteosarcoma metastatic – Treatment Sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rifabutin Vh4524184 Tuvusertib Argon Cyanocobalamin Febuxostat Inupadenant Clindamycin Hydrochloride NERANDOMILAST Clenbuterol Hydrochloride Cangrelor Tetrasodium Calcium Pantothenate Bp Maralixibat Chloride Pevonedistat Human Immunoglobulin G Aspartic Acid Cinchocaine Hydrochloride M2Rlab HUPERZINE A 18F-Psma-1007 More therapies…

    Learn about Your Condition

    Proteinuria Osteoporosis Chorioretinitis Thrombosis Crohn's disease Laparoscopic surgery Malignant neoplasm of choroid Hip fracture Radius fracture Oesophageal carcinoma Uterine cancer Metastatic glioma Paedophilia Cutaneous calcification Abortion threatened More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina…

Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie

Ul. Fryderyka Szopena 2, Rzeszow, 35-055, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

    Recruiting

    2 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Germany Poland

  • Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Topotecan
    Belgium France Germany Greece Hungary Italy +5

  • Evaluation of remibrutinib (LOU064) effectiveness and safety in adult patients with chronic urticaria: A 12-week placebo-controlled study

    Recruiting

    2 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Remibrutinib
    France Germany Poland Spain

  • Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Rituximab
    Poland

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Alpha-Ketophenylalanine Calcium
    • Hydroxi-Methionine Calcium
    • Keto-Isoleucine Calcium
    Poland

  • Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytisine
    Poland

  • Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Bulgaria France Germany Hungary Italy +5

  • Study on Risankizumab for Children Aged 6-17 With Moderate to Severe Plaque Psoriasis After Completing Previous Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Risankizumab
    Germany Poland Spain

  • ICP-332 for Adults with Prurigo Nodularis

    Recruiting

    2 1
    Austria Belgium France Germany Poland
Previous Page
1 2 3 4 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!